These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 378593)

  • 1. [Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies].
    Tidow G; Bunzendahl H; Wonigeit K; Pichlmayr R
    Chir Forum Exp Klin Forsch; 1979; ():325-8. PubMed ID: 378593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy].
    Bullinger W; Hammer C; Land W; Welter H
    Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved results in high risk cadaveric kidney transplantation.
    Toledo-Pereyra LH; Baskin S; McNichol L; Edford G; Whitten J; Allaben R
    Proc Clin Dial Transplant Forum; 1980; 10():289-92. PubMed ID: 7050990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe kidney graft rejection in combined kidney and pancreas transplantation.
    Hedman L; Frisk B; Brynger H; Frödin L; Tufveson G; Wahlberg J
    Transplant Proc; 1987 Oct; 19(5):3911-2. PubMed ID: 3313961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
    Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L
    Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
    Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
    Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on pathogenesis and treatment of rejection in kidney transplantation.
    Merrill JP
    Kidney Int Suppl; 1975 Feb; (3):318-22. PubMed ID: 1099311
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroids and rejection treatment in the Gothenburg transplant programme.
    Brynger H; Gelin LE
    Proc Eur Dial Transplant Assoc; 1980; 17():395-403. PubMed ID: 7017681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation.
    Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE
    Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute rejection episodes after renal transplantation in children.
    Hoyer PF; Offner G; Brodehl J
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.